Sebastian Kull is an accomplished analyst in health economics and market access, with a strong educational background in bioentrepreneurship and molecular biotechnology. Kull holds a Master's degree from the renowned Karolinska Institute in Stockholm, Sweden, and a Bachelor's degree from Heidelberg University in Germany, where he specialized in biotechnology. His experience includes working as a Market Access Analyst and an Associate Consultant at Synergus AB, where he developed his expertise in pharmaceuticals and medical technology. Additionally, Kull has worked as a research assistant and intern in various organizations, including Industrifonden, aquila biolabs, and heipha Dr. Müller GmbH. He has a deep interest in health care innovation and research, complemented by his strong analytical skills and his experience with industry players.